Department of Vascular Surgery, Valladolid University Hospital, Valladolid, Spain.
Department of Vascular Surgery, Getafe University Hospital, Madrid, Spain.
Ann Vasc Surg. 2021 May;73:86-96. doi: 10.1016/j.avsg.2021.01.054. Epub 2021 Jan 22.
To analyze the outcome of vascular procedures performed in patients with COVID-19 infection during the 2020 pandemic.
This is a multicenter, prospective observational cohort study. We analyzed data from 75 patients with COVID-19 infection undergoing vascular surgery procedures in 17 hospitals across Spain and Andorra between March and May 2020. The primary end point was 30-day mortality. Clinical Trials registry number NCT04333693.
The mean age was 70.9 (45-94) and 58 (77.0%) patients were male. Around 70.7% had postoperative complications, 36.0% of patients experienced respiratory failure, 22.7% acute renal failure, and 22.7% acute respiratory distress syndrome (ARDS). All-cause 30-days mortality rate was 37.3%. Multivariate analysis identified age >65 years (P = 0.009), American Society of Anesthesiologists (ASA) classification IV (P = 0.004), preoperative lymphocyte count <0.6 (×10/L) (P = 0.001) and lactate dehydrogenase (LDH) >500 (UI/L) (P = 0.004), need for invasive ventilation (P = 0.043), postoperative acute renal failure (P = 0.001), ARDS (P = 0.003) and major amputation (P = 0.009) as independent variables associated with mortality. Preoperative coma (P = 0.001), quick Sepsis Related Organ Failure Assessment (qSOFA) score ≥2 (P = 0.043), lymphocytes <0.6 (×10/L) (P = 0.019) leucocytes >11.5 (×10/L) (P = 0.007) and serum ferritin >1800 mg/dL (P = 0.004), bilateral lung infiltrates on thorax computed tomography (P = 0.025), and postoperative acute renal failure (P = 0.009) increased the risk of postoperative ARDS. qSOFA score ≥2 was the only risk factor associated with postoperative sepsis (P = 0.041).
Patients with COVID-19 infection undergoing vascular surgery procedures showed poor 30-days survival. Age >65 years, preoperative lymphocytes <0.6 (x10/L) and LDH >500 (UI/L), and postoperative acute renal failure, ARDS and need for major amputation were identified as prognostic factors of 30-days mortality.
分析 2020 年大流行期间 COVID-19 感染患者行血管手术的结果。
这是一项多中心前瞻性观察队列研究。我们分析了 2020 年 3 月至 5 月期间在西班牙和安道尔的 17 家医院接受 COVID-19 感染血管手术的 75 例患者的数据。主要终点为 30 天死亡率。临床试验注册号 NCT04333693。
平均年龄为 70.9(45-94)岁,58 例(77.0%)为男性。约 70.7%的患者术后发生并发症,36.0%的患者发生呼吸衰竭,22.7%的患者发生急性肾衰竭,22.7%的患者发生急性呼吸窘迫综合征(ARDS)。全因 30 天死亡率为 37.3%。多变量分析确定年龄>65 岁(P=0.009)、美国麻醉医师协会(ASA)分类 IV 级(P=0.004)、术前淋巴细胞计数<0.6(×10/L)(P=0.001)和乳酸脱氢酶(LDH)>500(UI/L)(P=0.004)、需要有创通气(P=0.043)、术后急性肾衰竭(P=0.001)、ARDS(P=0.003)和大截肢(P=0.009)是与死亡率相关的独立变量。术前昏迷(P=0.001)、快速脓毒症相关器官衰竭评估(qSOFA)评分≥2(P=0.043)、淋巴细胞<0.6(×10/L)(P=0.019)、白细胞>11.5(×10/L)(P=0.007)和血清铁蛋白>1800mg/dL(P=0.004)、胸部计算机断层扫描(CT)双侧肺浸润(P=0.025)和术后急性肾衰竭(P=0.009)增加术后发生 ARDS 的风险。qSOFA 评分≥2 是与术后脓毒症相关的唯一危险因素(P=0.041)。
COVID-19 感染患者行血管手术显示 30 天生存率较差。年龄>65 岁、术前淋巴细胞计数<0.6(x10/L)和 LDH>500(UI/L)以及术后急性肾衰竭、ARDS 和需要大截肢被确定为 30 天死亡率的预后因素。